Title: Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study
Authors: Russell-Jones, David ×
Cuddihy, Robert M
Hanefeld, Markolf
Kumar, Ajay
González, Jose G
Chan, Melanie
Wolka, Anne M
Boardman, Marilyn K
DURATION-4 Study Group #
Contributors: Mathieu, Chantal
Issue Date: Feb-2012
Publisher: American Diabetes Association
Series Title: Diabetes Care vol:35 issue:2 pages:252-258
Abstract: To test the safety and efficacy of exenatide once weekly (EQW) compared with metformin (MET), pioglitazone (PIO), and sitagliptin (SITA) over 26 weeks, in suboptimally treated (diet and exercise) drug-naive patients with type 2 diabetes.
ISSN: 0149-5992
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Clinical and Experimental Endocrinology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science